NL-OMON26912尚未招募不适用
Pharmacokinetics in type 2 diabetes mellitus patients using bedaquiline for tuberculosis; A single dose, open-label, prospective pilot study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy volunteers must meet all of the following criteria In order to be eligible to participate in this study:
- •-Between 18 and 50 years of age
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •- Drug hypersensitivity to bedaquiline.
研究者
相似试验
招募中
1 期
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes IIPlatelet AggregationAspirinPlatelet Aggregation InhibitorsType 2 DiabetesDiabetes Mellitus, Type 2NCT05702463Montreal Heart Institute30
进行中（未招募）
早期 1 期
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE DiabetesDiabetes Mellitus, Type 2NCT05105919Montreal Heart Institute50
未知
2 期
A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal DysfunctioType 2 diabetes mellitus with renal dysfunctionJPRN-jRCT2080221237Taisho Pharmaceutical co., LTD50
撤回
1 期
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02623465Eli Lilly and Company
已完成
1 期
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02703337Eli Lilly and Company30